Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer's disease.

MLA

Fine, Jared M., et al. “Low-Dose Intranasal Deferoxamine Modulates Memory, Neuroinflammation, and the Neuronal Transcriptome in the Streptozotocin Rodent Model of Alzheimer’s Disease.” Frontiers in Neuroscience, Jan. 2025, pp. 1–12. EBSCOhost, https://doi.org/10.3389/fnins.2024.1528374.

APA

Fine, J. M., Kosyakovsky, J., Bowe, T. T., Faltesek, K. A., Stroebel, B. M., Abrahante, J. E., Kelly, M. R., Thompson, E. A., Westby, C. M., Robertson, K. M., Frey II, W. H., & Hanson, L. R. (2025). Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer’s disease. Frontiers in Neuroscience, 1–12. https://doi.org/10.3389/fnins.2024.1528374

Chicago

Fine, Jared M., Jacob Kosyakovsky, Tate T. Bowe, Katherine A. Faltesek, Benjamin M. Stroebel, Juan E. Abrahante, Michael R. Kelly, et al. 2025. “Low-Dose Intranasal Deferoxamine Modulates Memory, Neuroinflammation, and the Neuronal Transcriptome in the Streptozotocin Rodent Model of Alzheimer’s Disease.” Frontiers in Neuroscience, January, 1–12. doi:10.3389/fnins.2024.1528374.